Cytochrome P-450-dependent HETEs

Profile of biological activity and stimulation by vasoactive peptides

Mairead A. Carroll, Michael Balazy, Patricia Margiotta, Dong Dong Huang, J. R. Falck, John C. McGiff

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

The cytochrome P-450 pathway is capable of metabolizing arachidonic acid to ω- and subterminal hydroxylase metabolites, 16-, 17-, 18-, 19-, and 20- hydroxyeicosatetraenoic acids (P-450 HETEs). We have quantitated, by gas chromatography-mass spectrometry (GC/MS), endogenous HETEs exiting the rabbit isolated perfused kidney elicited by hormonal stimulation. Kidneys were perfused with Krebs-Henseleit solution containing indomethacin (2.8 μM) to prevent further metabolism of HETEs by cyclooxygenase. Phenylephrine (2-3 μM) was added to the perfusate to raise perfusion pressure to ~80 mmHg. Angiotensin II (ANG II), arginine vasopressin (AVP), and bradykinin (BK) were injected into the renal artery and perfusates collected throughout the vasoactive response. After addition of an internal standard, deuterated 19- HETE, perfusates were extracted and purified and P-450 HETEs were derivatized for GC/MS analysis. Under basal conditions, 16-, 18-, 19-, and 20-HETEs were released (range: 50-270 pg/ml), 19-HETE being the highest and fivefold greater than 16-HETE, the lowest. Injection of 50 ng ANG II increased by two- to sixfold P-450 HETE release associated with an increase of 40 ± 11 mmHg in perfusion pressure. An equipressor dose of AVP (50 ng) did not release P- 450 HETEs nor did a 5-μg dose of the vasodilator peptide BK, which decreased perfusion pressure by 22 ± 6 mmHg. Authentic 19- and 20-HETE isomers resulted in dose-dependent dilation, as did 18(R)- and 16(R)-HETEs, whereas their enantiomers and 17-HETE isomers were without effect on perfusion pressure. The vasodilator effects of 18(R)- and 16(R)-HETEs, like 20- and 19- HETEs, were inhibited by indomethacin. Furthermore, P-450 HETEs exhibited both regio- and stereoselective inhibition of proximal tubule adenosine triphosphatase (ATPase) activity. The (S) enantiomers of 16- and 17-HETE potently inhibited activity, whereas their (R) isomers and other P-450 HETEs had negligible effects on ATPase activity. The quantity of HETEs released from the kidney, either under basal conditions or when stimulated by ANG II, and their biological profile suggest that subterminal HETEs may participate in renal mechanisms affecting vasomotion and tubular transport.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume271
Issue number4 40-4
StatePublished - Oct 1996

Fingerprint

Hydroxyeicosatetraenoic Acids
Cytochrome P-450 Enzyme System
Peptides
Perfusion
Angiotensin II
Kidney
Pressure
Arginine Vasopressin
Bradykinin
Vasodilator Agents
Indomethacin
Gas Chromatography-Mass Spectrometry
Adenosine Triphosphatases
Phenylephrine
Renal Artery
Prostaglandin-Endoperoxide Synthases
Mixed Function Oxygenases
Arachidonic Acid
Dilatation
19-hydroxy-5,8,11,14-eicosatetraenoic acid

Keywords

  • adenosine triphosphatase activity
  • angiotensin II
  • hydroxyeicosatetraenoic acids
  • renal cytochrome P-450
  • vasodilation

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Cytochrome P-450-dependent HETEs : Profile of biological activity and stimulation by vasoactive peptides. / Carroll, Mairead A.; Balazy, Michael; Margiotta, Patricia; Huang, Dong Dong; Falck, J. R.; McGiff, John C.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 271, No. 4 40-4, 10.1996.

Research output: Contribution to journalArticle

Carroll, Mairead A. ; Balazy, Michael ; Margiotta, Patricia ; Huang, Dong Dong ; Falck, J. R. ; McGiff, John C. / Cytochrome P-450-dependent HETEs : Profile of biological activity and stimulation by vasoactive peptides. In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 1996 ; Vol. 271, No. 4 40-4.
@article{e39bb753b6174ba8aa2e3bf3e19fb30b,
title = "Cytochrome P-450-dependent HETEs: Profile of biological activity and stimulation by vasoactive peptides",
abstract = "The cytochrome P-450 pathway is capable of metabolizing arachidonic acid to ω- and subterminal hydroxylase metabolites, 16-, 17-, 18-, 19-, and 20- hydroxyeicosatetraenoic acids (P-450 HETEs). We have quantitated, by gas chromatography-mass spectrometry (GC/MS), endogenous HETEs exiting the rabbit isolated perfused kidney elicited by hormonal stimulation. Kidneys were perfused with Krebs-Henseleit solution containing indomethacin (2.8 μM) to prevent further metabolism of HETEs by cyclooxygenase. Phenylephrine (2-3 μM) was added to the perfusate to raise perfusion pressure to ~80 mmHg. Angiotensin II (ANG II), arginine vasopressin (AVP), and bradykinin (BK) were injected into the renal artery and perfusates collected throughout the vasoactive response. After addition of an internal standard, deuterated 19- HETE, perfusates were extracted and purified and P-450 HETEs were derivatized for GC/MS analysis. Under basal conditions, 16-, 18-, 19-, and 20-HETEs were released (range: 50-270 pg/ml), 19-HETE being the highest and fivefold greater than 16-HETE, the lowest. Injection of 50 ng ANG II increased by two- to sixfold P-450 HETE release associated with an increase of 40 ± 11 mmHg in perfusion pressure. An equipressor dose of AVP (50 ng) did not release P- 450 HETEs nor did a 5-μg dose of the vasodilator peptide BK, which decreased perfusion pressure by 22 ± 6 mmHg. Authentic 19- and 20-HETE isomers resulted in dose-dependent dilation, as did 18(R)- and 16(R)-HETEs, whereas their enantiomers and 17-HETE isomers were without effect on perfusion pressure. The vasodilator effects of 18(R)- and 16(R)-HETEs, like 20- and 19- HETEs, were inhibited by indomethacin. Furthermore, P-450 HETEs exhibited both regio- and stereoselective inhibition of proximal tubule adenosine triphosphatase (ATPase) activity. The (S) enantiomers of 16- and 17-HETE potently inhibited activity, whereas their (R) isomers and other P-450 HETEs had negligible effects on ATPase activity. The quantity of HETEs released from the kidney, either under basal conditions or when stimulated by ANG II, and their biological profile suggest that subterminal HETEs may participate in renal mechanisms affecting vasomotion and tubular transport.",
keywords = "adenosine triphosphatase activity, angiotensin II, hydroxyeicosatetraenoic acids, renal cytochrome P-450, vasodilation",
author = "Carroll, {Mairead A.} and Michael Balazy and Patricia Margiotta and Huang, {Dong Dong} and Falck, {J. R.} and McGiff, {John C.}",
year = "1996",
month = "10",
language = "English (US)",
volume = "271",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4 40-4",

}

TY - JOUR

T1 - Cytochrome P-450-dependent HETEs

T2 - Profile of biological activity and stimulation by vasoactive peptides

AU - Carroll, Mairead A.

AU - Balazy, Michael

AU - Margiotta, Patricia

AU - Huang, Dong Dong

AU - Falck, J. R.

AU - McGiff, John C.

PY - 1996/10

Y1 - 1996/10

N2 - The cytochrome P-450 pathway is capable of metabolizing arachidonic acid to ω- and subterminal hydroxylase metabolites, 16-, 17-, 18-, 19-, and 20- hydroxyeicosatetraenoic acids (P-450 HETEs). We have quantitated, by gas chromatography-mass spectrometry (GC/MS), endogenous HETEs exiting the rabbit isolated perfused kidney elicited by hormonal stimulation. Kidneys were perfused with Krebs-Henseleit solution containing indomethacin (2.8 μM) to prevent further metabolism of HETEs by cyclooxygenase. Phenylephrine (2-3 μM) was added to the perfusate to raise perfusion pressure to ~80 mmHg. Angiotensin II (ANG II), arginine vasopressin (AVP), and bradykinin (BK) were injected into the renal artery and perfusates collected throughout the vasoactive response. After addition of an internal standard, deuterated 19- HETE, perfusates were extracted and purified and P-450 HETEs were derivatized for GC/MS analysis. Under basal conditions, 16-, 18-, 19-, and 20-HETEs were released (range: 50-270 pg/ml), 19-HETE being the highest and fivefold greater than 16-HETE, the lowest. Injection of 50 ng ANG II increased by two- to sixfold P-450 HETE release associated with an increase of 40 ± 11 mmHg in perfusion pressure. An equipressor dose of AVP (50 ng) did not release P- 450 HETEs nor did a 5-μg dose of the vasodilator peptide BK, which decreased perfusion pressure by 22 ± 6 mmHg. Authentic 19- and 20-HETE isomers resulted in dose-dependent dilation, as did 18(R)- and 16(R)-HETEs, whereas their enantiomers and 17-HETE isomers were without effect on perfusion pressure. The vasodilator effects of 18(R)- and 16(R)-HETEs, like 20- and 19- HETEs, were inhibited by indomethacin. Furthermore, P-450 HETEs exhibited both regio- and stereoselective inhibition of proximal tubule adenosine triphosphatase (ATPase) activity. The (S) enantiomers of 16- and 17-HETE potently inhibited activity, whereas their (R) isomers and other P-450 HETEs had negligible effects on ATPase activity. The quantity of HETEs released from the kidney, either under basal conditions or when stimulated by ANG II, and their biological profile suggest that subterminal HETEs may participate in renal mechanisms affecting vasomotion and tubular transport.

AB - The cytochrome P-450 pathway is capable of metabolizing arachidonic acid to ω- and subterminal hydroxylase metabolites, 16-, 17-, 18-, 19-, and 20- hydroxyeicosatetraenoic acids (P-450 HETEs). We have quantitated, by gas chromatography-mass spectrometry (GC/MS), endogenous HETEs exiting the rabbit isolated perfused kidney elicited by hormonal stimulation. Kidneys were perfused with Krebs-Henseleit solution containing indomethacin (2.8 μM) to prevent further metabolism of HETEs by cyclooxygenase. Phenylephrine (2-3 μM) was added to the perfusate to raise perfusion pressure to ~80 mmHg. Angiotensin II (ANG II), arginine vasopressin (AVP), and bradykinin (BK) were injected into the renal artery and perfusates collected throughout the vasoactive response. After addition of an internal standard, deuterated 19- HETE, perfusates were extracted and purified and P-450 HETEs were derivatized for GC/MS analysis. Under basal conditions, 16-, 18-, 19-, and 20-HETEs were released (range: 50-270 pg/ml), 19-HETE being the highest and fivefold greater than 16-HETE, the lowest. Injection of 50 ng ANG II increased by two- to sixfold P-450 HETE release associated with an increase of 40 ± 11 mmHg in perfusion pressure. An equipressor dose of AVP (50 ng) did not release P- 450 HETEs nor did a 5-μg dose of the vasodilator peptide BK, which decreased perfusion pressure by 22 ± 6 mmHg. Authentic 19- and 20-HETE isomers resulted in dose-dependent dilation, as did 18(R)- and 16(R)-HETEs, whereas their enantiomers and 17-HETE isomers were without effect on perfusion pressure. The vasodilator effects of 18(R)- and 16(R)-HETEs, like 20- and 19- HETEs, were inhibited by indomethacin. Furthermore, P-450 HETEs exhibited both regio- and stereoselective inhibition of proximal tubule adenosine triphosphatase (ATPase) activity. The (S) enantiomers of 16- and 17-HETE potently inhibited activity, whereas their (R) isomers and other P-450 HETEs had negligible effects on ATPase activity. The quantity of HETEs released from the kidney, either under basal conditions or when stimulated by ANG II, and their biological profile suggest that subterminal HETEs may participate in renal mechanisms affecting vasomotion and tubular transport.

KW - adenosine triphosphatase activity

KW - angiotensin II

KW - hydroxyeicosatetraenoic acids

KW - renal cytochrome P-450

KW - vasodilation

UR - http://www.scopus.com/inward/record.url?scp=0029907840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029907840&partnerID=8YFLogxK

M3 - Article

VL - 271

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 4 40-4

ER -